Clinical Trial Update: The Development of MASLD Among Survivors of Breast or Colorectal Cancer

View source ↗

Summary

A recruiting study led by the University of Bern to examine the development of metabolic dysfunction-associated steatotic liver disease (MASLD) in survivors of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: University of Bern | Conditions: Breast Cancer Survivors, Colorectal (Colon or Rectal) Cancer Survivors | Status: RECRUITING